Analyst Ratings for YS Biopharma Co. (YS)

YS Rating Summary

  |   Expand Research on YS
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 10 / 10
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
11/13/2023 Noble Capital N/A New Coverage Outperform
(N/A)		 5.25
(N/A)		 0.60
(1.02)		 70% Details